Brendan Bulik-Sullivan

Brendan Bulik-Sullivan is a general partner at GV, where he focuses on life sciences investments.

Before GV, Brendan’s career focused on applied statistics and machine learning research in genetics and biotechnology. He designed machine learning models for personalized immuno-oncology therapeutics at Gritstone Oncology and developed methods for statistical genetics research at the Broad Institute. Brendan’s work has been published in journals including Nature, Science, Nature Biotechnology, and Nature Genetics. In his free time, Brendan enjoys reviewing data and reading scientific journals. Brendan is interested in innovative therapeutic biotechnology and diagnostics across all stages and therapeutic areas.

Brendan has a B.A. in mathematics from the University of California, Berkeley, and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.